go to medicines.ie homepage
  • Home  |  
  • About  |  
  • Links  |  
  • Help
Font Size
Search for:  
select
select
  • SPCs and PILs
  • SPCs Only
  • PILs Only
  Advanced Search
  • What's
    New
      
  • Browse
    Medicines
      
  • Browse
    Active Ingredients
      
  • Browse
    Companies
      
  • Codes
    of Practice
      
  • Adverse
    Reaction Reporting

Janssen-Cilag Ltd

Janssen-Cilag Ltd
50 - 100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG , UK
Telephone: +44 1494 567 567
Fax: +44 1494 567 568
Medical Information Direct Line: +353 1 800 709 122
Medical Information e-mail: medinfo@janssen-cilag.co.uk
Customer Care direct line: +353 1 620 2300
Summary of Product Characteristics last updated on medicines.ie: 26/01/2012
SPC Gyno-Daktarin 1200mg Vaginal Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 26/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to section 3 - Pharmaceutical form
  • Change to section 6.3 - Shelf life
  • Change to section 6.4 - Special precautions for storage
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   20-Jan-2012
Legal Category:   Product subject to medical prescription which may be renewed (B)

Free-text change information supplied by the pharmaceutical company



3 PHARMACEUTICAL FORM

Vaginal capsule, soft.

White to off white egg shaped soft vaginal capsule containing a white to cream coloured hydrophobic mass.

 

 

6.3 Shelf life

24 months 5 years

 

6.4 Special precautions for storage

Do not store above   25 30°C. Store in the original package to protect from light and moisture.

 

10 DATE OF REVISION OF THE TEXT

  01 June 2010  20 January 2012

Updated on 30/06/2010 and displayed until 26/01/2012
Reasons for adding or updating:
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 6.4 - Special precautions for storage
  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   01-Jun-2010
Legal Category:   Product subject to medical prescription which may be renewed (B)

Free-text change information supplied by the pharmaceutical company



Change to section 2 - Qualitative and quantitative composition

Addition of: Also contains ethyl parahydroxybenzoate (E125) and sodium propyl parahydroxybenzotae (E

Change to section 6.4 - Special precautions for storage

 

Addition of :  to protect from light and moisture.

 

Change to section 9 - Date of renewal of authorisation

 09 June 2009

Change to section 10 - Date of revision of the text

June 2010

Updated on 24/04/2008 and displayed until 30/06/2010
Reasons for adding or updating:
  • Change to section 7 - Marketing authorisation holder
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   04/2008
Legal Category:   prescription only

Free-text change information supplied by the pharmaceutical company

Change to section 7 – Marketing Authorisation Holder

50 100 Holmers Farm Way

High Wycombe

Bucks

HP12 4EG

UK

Change to section 10 – Date of revision of the text

17th April 2008

Updated on 09/04/2008 and displayed until 24/04/2008
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable effects
  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   04/2008
Legal Category:   prescription only

Free-text change information supplied by the pharmaceutical company

Change to section 4.8 – Undesirable effects

 Minor changes to the frequency of adverse events in table 1. Addition of Table 2 adverse events. Postmarketing adverse events was table 2 now table 3

 

 

Change to section 9 – Date of Renewal of Authorisation

 

Change to section 10 – Date of revision of the text

3rd April 2008

 

 

Updated on 05/01/2007 and displayed until 09/04/2008
Reasons for adding or updating:
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.8 - Undesirable effects
  • Change to section 4.9 - Overdose
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 5.3 - Preclinical safety data
  • Change to section 6.6 - Special precautions for disposal and other handling
  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   12/2006
Legal Category:   prescription only

Free-text change information supplied by the pharmaceutical company

 

Change to section 2 – quantitative and qualitative composition

Addition of standard statement

Change to section 4.2 – Posology and |Method of Administration

Changed for clarification

Change to section 4.4 – Special Warnings and Precautions for Use

Update warnings

Change to section 4.5 –Interaction with other medicinal products and other forms of interaction

Update interactions

Change to section 4.6 – Pregnancy and Lactation

Update warnings

Change to section 4.8 – Undesirable effects

Update undesirable effects

Change to section 4.9 - Overdose

Update information

Change to section 5.1 - Pharmacodynamic properties

Update information

Change to section 5.2 - Pharmacokinetic properties

Update information

Change to section 5.3 - Preclinical Safety Data

Update information

Change to section 6.6 –  Instructions for use, handling and disposal

Update headings

Change to section 9 – Date of Renewal of Authorisation

Update dates

Change to section 10 – Date of revision of text

Update dates

Updated on 23/11/2006 and displayed until 05/01/2007
Reasons for adding or updating:
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 6.6 - Special precautions for disposal and other handling
  • Change to section 10 - Date of revision of the text
  • Change to separate SPCs covering individual presentations
Date of revision of text on the SPC:   11/2006
Legal Category:   prescription only

Free-text change information supplied by the pharmaceutical company

2.

QUALITATIVE AND QUANTITATIVE COMPOSITION

Update to include the statement ‘for full list of excipients…

 

6.6

Instructions for use, handling and disposal

Update Title of this section of the SPC.

 

10.

DATE OF REVISION OF THE TEXT

 

November 2006

 

 

 

Change to separate SPCs covering individual presentations                                                                                                                                                                                                      

 

Updated on 07/11/2006 and displayed until 23/11/2006
Reasons for adding or updating:
  • Change to section 6.5 - Nature and contents of container
  • Change to section 10 - Date of revision of the text
  • Addition of separate SPCs covering individual presentations
Date of revision of text on the SPC:   10/2006
Legal Category:   prescription only

Free-text change information supplied by the pharmaceutical company

6.5

Nature and contents of container

Change to this section to remove reference to the fingerstall as it will no longer be included in the pack.

10.

DATE OF REVISION OF THE TEXT

October 2006

 

 

 

Change to separate SPCs covering individual presentations                                                                                                                                                                                                      

X

 

Updated on 08/05/2006 and displayed until 07/11/2006
Reasons for adding or updating:
  • New SPC for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Miconazole nitrate

Versions

 
26/01/2012 to Current
30/06/2010 to 26/01/2012
24/04/2008 to 30/06/2010
09/04/2008 to 24/04/2008
05/01/2007 to 09/04/2008
23/11/2006 to 05/01/2007
07/11/2006 to 23/11/2006
08/05/2006 to 07/11/2006
  • Terms & Conditions | 
  • Accessibility | 
  • Privacy Statement | 
  • Contact Us

Registered Address: Franklin House, 140 Pembroke Road, Dublin 4, Ireland
Registered Number: 254776
Tel: (353 1) 6603350 Fax: (353 1) 6686672 Email: info@ipha.ie

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information: verify here.

logo